Financials data is unavailable for this security.
View more
Year on year Goldenwell Biotech Inc had revenues fall -95.10% from 47.80k to 2.34k, though the company grew net income from a loss of 985.10k to a smaller loss of 116.90k.
| Gross margin | 42.55% |
|---|---|
| Net profit margin | -14,586.17% |
| Operating margin | -14,586.17% |
| Return on assets | -69.82% |
|---|---|
| Return on equity | -189.43% |
| Return on investment | -70.29% |
More ▼
Cash flow in USDView more
In 2023, Goldenwell Biotech Inc increased its cash reserves by 15.72%, or 7.23k. Cash Flow from Financing totalled 121.92k or 5,210.26% of revenues. In addition the company used 114.69k for operations while cash used for investing totalled .
| Cash flow per share | -0.0014 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.00004 |
|---|---|
| Tangible book value per share | 0.00004 |
More ▼
Balance sheet in USDView more
| Current ratio | 167.00 |
|---|---|
| Quick ratio | 21.43 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
